Published in Vaccine Weekly, October 18th, 1999
The development of combined vaccines constitutes one of the priorities in modern vaccine research. One of the most successful combined vaccines in use is the diphtheria-pertussis-tetanus vaccine. However, concerns about the safety of the pertussis arm have led to decreased acceptance of the vaccine and also to the development of new, safer, and effective acellular vaccines against pertussis.
"Unfortunately, the production cost of these new vaccines is significantly higher than that of previous vaccines," B. Abomoelak and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.